Publications

Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review. Wiley AM, Yang J, Madhani R, Nath A, Totah RA. Drug Metab Rev. 2024 Mar 20:1-19. doi: 10.1080/03602532.2024.2329928. Online ahead of print. PMID: 38478383 Review.

Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury. Lidberg KA, Muthusamy S, Adil M, Mahadeo A, Yang J, Patel RS, Wang L, Bammler TK, Reichel J, Yeung CK, Himmelfarb J, Kelly EJ, Akilesh S. J Am Soc Nephrol. 2022 May;33(5):949-965. doi: 10.1681/ASN.2021060751. Epub 2022 Feb 23.

Gutsy science: In vitro systems of the human intestine to model oral drug disposition. Arian CM, Imaoka T, Yang J, Kelly EJ, Thummel KE. Pharmacol Ther. 2022 Feb;230:107962. doi: 10.1016/j.pharmthera.2021.107962. Epub 2021 Aug 31.

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing. Chen WY, Evangelista EA, Yang J, Kelly EJ, Yeung CK. Front Pharmacol. 2021 Jul 26;12:695920. doi: 10.3389/fphar.2021.695920. eCollection 2021.

Microphysiological system modeling of ochratoxin A-associated nephrotoxicity. Imaoka T, Yang J, Wang L, McDonald MG, Afsharinejad Z, Bammler TK, Van Ness K, Yeung CK, Rettie AE, Himmelfarb J, Kelly EJ. Toxicology. 2020 Nov;444:152582. doi: 10.1016/j.tox.2020.152582. Epub 2020 Sep 6.